About the HAS-BLED score
HAS-BLED is a bleeding-risk score for patients taking anticoagulation, most commonly for atrial fibrillation. It was published by Pisters and colleagues in 2010 to give clinicians a simple, structured way to estimate the annual risk of major bleeding alongside stroke-risk tools such as CHA2DS2-VASc. Like most bedside risk scores, it converts a short checklist of clinical facts into a single number from 0 to 9 that rises with bleeding risk.
How the score is built
HAS-BLED is an acronym for its seven components, each worth points as follows:
- H - Hypertension: systolic blood pressure above 160 mmHg - 1 point.
- A - Abnormal renal and liver function: 1 point for abnormal renal function (dialysis, transplant, or creatinine above roughly 2.26 mg/dL) and 1 point for abnormal liver function (chronic hepatic disease such as cirrhosis, or bilirubin more than twice normal with AST/ALT/ALP more than three times normal) - up to 2 points total.
- S - Stroke history: prior stroke - 1 point.
- B - Bleeding history or predisposition: prior major bleeding or a condition that predisposes to bleeding, such as anemia - 1 point.
- L - Labile INR: for patients on warfarin, unstable INR values or time in therapeutic range under 60% - 1 point.
- E - Elderly: age over 65 years - 1 point.
- D - Drugs or alcohol: 1 point for concurrent antiplatelet or NSAID use and 1 point for heavy alcohol use - up to 2 points total.
Adding every component gives a total from 0 to 9. Because the renal/liver and drugs/alcohol components can each contribute up to 2 points, a patient can reach a higher score even without hitting every one of the seven letters.
Interpreting the result
In the original validation cohort, the approximate rate of major bleeding per 100 patient-years rose with the score: about 1.13 at a score of 0, 1.02 at 1, 1.88 at 2, 3.74 at 3, 8.70 at 4, and roughly 12.50 at 5 or higher (few patients in the derivation cohort scored above 5, so estimates that high are less precise). Scores are commonly grouped as low risk (0-1), intermediate risk (2), and high risk (3 or more). A high score is generally treated as a prompt to monitor more closely and correct modifiable risk factors - such as blood pressure, concurrent antiplatelet use, or alcohol intake - rather than an automatic reason to withhold anticoagulation, since the stroke risk being treated often still outweighs the bleeding risk.
When to consult a professional
This tool performs the standard HAS-BLED arithmetic for education and reference. It does not diagnose bleeding risk, dose or adjust anticoagulants, or replace clinical judgment. Any decision about starting, continuing, or stopping anticoagulation should be made with a licensed healthcare provider who can weigh this score alongside the patient's full history and stroke risk.